OCT 30, 2014 06:00 AM PDT

A platform for combining the results of WES and RNA-seq analysis

Speakers
  • Director, Clinical Analytics and Workflow Products, CLC Bio, a Qiagen company
    Biography
      Naomi is greatly experienced within the field of bioinformatics from where she has gained a tremendous amount of customer, product, and sequencing experience through the past 15 years. Naomis pre-business experience is loaded with nucleic acids and oncology at Bristol-Myers Squibb and The Wistar Institute, along with an MBA from La Salle University. Naomi has also been working 10 years as a Product Manager and nearly five years as an NGS Key Account Manager before heading the product management of Clinical Analytics and Workflow products at QIAGEN.

    Abstract:

    Cancer research is being revolutionized by targeted gene panels, whole exome sequencing (WES), whole genome sequencing (WGS), and transcriptome sequencing (RNA-Seq). Many analyses, such as comparison of tumor and normal cells, include comparison of variant calls. In this webinar, we will illustrate the benefits of leveraging read mappings in the comparison of WES and RNA-seq data using CLC Cancer Research Workbench. The CLC platform provides a number of tools, together building up a workflow, for analyzing WES and RNA-seq reads and for comparing the results. From this webinar you will learn how to analyse and compare variants from two patients using built-in workflows in CLC Cancer Research Workbench; Analysis steps include filtering results for tumor-specific variants, identifying variants from both WES and RNA-seq data, searching RNA-seq read mappings for variants previously called from exome data, and recovering previously detected variants in the WES data directly from the RNA-seq read mappings.


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    JUN 26, 2019 09:00 AM PDT
    C.E. CREDITS
    JUN 26, 2019 09:00 AM PDT
    DATE: June 26, 2019TIME: 9:00am PDT, 12:00pm EDT An excessive number of software solutions are available to help manage your clinical, biobank, or biorepository sample inform...
    MAR 26, 2019 02:00 PM PDT
    C.E. CREDITS
    MAR 26, 2019 02:00 PM PDT
    DATE:  March 26, 2019TIME:  2:00pm PDT, 5:00pm EDT  Prostate cancer is the second most common form of cancer in males, affecting one in eight men by the time t...
    Loading Comments...
    Show Resources